This topic contains a solution. Click here to go to the answer

Author Question: A premenopausal woman has ER-positive breast cancer, and her prescriber has ordered tamoxifen ... (Read 33 times)

acc299

  • Hero Member
  • *****
  • Posts: 569
A premenopausal woman has ER-positive breast cancer, and her prescriber has ordered tamoxifen (Nolvadex). She asks the nurse if anastrozole (Arimedex) would work better for her. What will the nurse tell her?
 
  a. Anastrozole is more likely to cause hot flushes than tamoxifen.
  b. Anastrozole is more likely to promote endometrial carcinoma.
  c. Cancer recurrence is higher with anastrozole.
  d. Until she is postmenopausal, anastrozole will not be effective.

Question 2

A 45-year-old patient with a family history of breast cancer is considering using tamoxifen (Nolvadex) for cancer prevention.
 
  The nurse performs a health history and learns that the woman had a child when she was 35 years old, that she has not had a hysterectomy, and that she experienced DVT when she was pregnant. What will the nurse tell the patient?
  a. Because of her family risk and late childbearing, this drug is a good choice for her.
  b. Her history of DVT outweighs any possible benefits she may have with this drug.
  c. Since she has not had a hysterectomy, the risk of endometrial cancer is too great.
  d. When she turns 50 years old, this drug will carry fewer risks for her.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amy.lauersdorf90

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

ANS: D
Anastrozole is used to treat ER-positive breast cancer in postmenopausal women. Because it does not block estrogen production in the ovaries, it is not effective in premenopausal women. It may cause hot flushes but is less likely to do so than tamoxifen. It is devoid of all estrogenic activity and does not promote endometrial cancer

Answer to Question 2

ANS: B
Tamoxifen is a good choice for women between the ages of 40 and 49 years as a cancer preventive, except for women at risk for DVT. Her family risk and late childbearing are indications for using tamoxifen, but only in women without increased risk of DVT. The risk of endometrial cancer increases with age and, without the risk of DVT, would not be a contraindication in a woman her age. Her risks of DVT do not change with age.




acc299

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
Gracias!


mammy1697

  • Member
  • Posts: 341
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

For a complete list of videos, visit our video library